Daniela Tomasoni (@danitomasoni_) 's Twitter Profile
Daniela Tomasoni

@danitomasoni_

Heart Failure Cardiologist
ASST Spedali Civili di Brescia, Italy

ID: 1659441547727732740

calendar_today19-05-2023 06:11:45

61 Tweet

133 Followers

159 Following

HFAPresident (@hfa_president) 's Twitter Profile Photo

#HeartFailure2024 Aficamtem for obstructive HCM. Effective and requires less monitoring. The results of SEQUOIA-HCM. Shall we remove “obstruction" from HCM? #HFA_ESC Martin Maron, MD

#HeartFailure2024 
Aficamtem for obstructive HCM. Effective and requires less monitoring. The results of SEQUOIA-HCM. Shall we remove “obstruction" from HCM?

#HFA_ESC <a href="/MartinMaronMD/">Martin Maron, MD</a>
Cornelia Margineanu (@corneliacrm) 's Twitter Profile Photo

Delightful news!📰 The first edition of the #HFAYoung Journal Club is on the way! 🗓️ June 5th 2024 ⏱️18:00 CET 📑 PUSH-AHF trial HFA Members: live and on demand access esc365.escardio.org/event/1635 Please provide questions you want us to ask the authors! #HFAWebinar #HFA_ESC

Delightful news!📰 
The first edition of the #HFAYoung Journal Club is on the way!

🗓️ June 5th 2024
⏱️18:00 CET
📑 PUSH-AHF trial

HFA Members: live and on demand access
esc365.escardio.org/event/1635

Please provide questions you want us to ask the authors!

#HFAWebinar #HFA_ESC
Henry Han (@hancardiomd) 's Twitter Profile Photo

Identifying reliable biomarkers for pulmonary congestion: Toward a close yet sustainable heart failure follow-up Traditional versus Biomarker-guided HF monitoring onlinelibrary.wiley.com/doi/full/10.10… European Society of Cardiology Journals Alberto Aimo EJHF Editor-in-Chief #EJHF

Identifying reliable biomarkers for pulmonary congestion: Toward a close yet sustainable heart failure follow-up 

Traditional versus Biomarker-guided HF monitoring 

onlinelibrary.wiley.com/doi/full/10.10… <a href="/ESC_Journals/">European Society of Cardiology Journals</a> <a href="/AlbertoAimo90/">Alberto Aimo</a> <a href="/EJHFEiC/">EJHF Editor-in-Chief</a> #EJHF
European Society of Cardiology Journals (@esc_journals) 's Twitter Profile Photo

What’s new in #HF June-July 24? smartphone-approach to #HF dx. #MRA efficacy + safety in pts with ⬇️ renal function. Timing to LVEF recovery 🤔? When #ICD. #SGLT2i in ATTR-CM ⬇️CV➕ HF🏥 👉 bit.ly/3xRJ7Sa EJHF Editor-in-Chief Amr Abdin Alberto Aimo Daniela Tomasoni

What’s new in #HF June-July 24?  smartphone-approach to #HF dx.
#MRA efficacy + safety in pts with ⬇️ renal function. Timing to LVEF recovery 🤔? When #ICD. #SGLT2i in ATTR-CM  ⬇️CV➕ HF🏥 
👉 bit.ly/3xRJ7Sa

<a href="/EJHFEiC/">EJHF Editor-in-Chief</a> <a href="/AmrAbdin10/">Amr Abdin</a> <a href="/AlbertoAimo90/">Alberto Aimo</a> <a href="/DaniTomasoni_/">Daniela Tomasoni</a>
JACC Journals (@jaccjournals) 's Twitter Profile Photo

A new paradigm for decongestion in acute #HeartFailure. Rapid uptitration of neurohormonal blockade after HF hospitalization is associated with effective, sustainable decongestion and better outcomes. bit.ly/4bIRYU1 #JACC #STRONGHF Piotr Ponikowski Daniela Tomasoni

A new paradigm for decongestion in acute #HeartFailure. Rapid uptitration of neurohormonal blockade after HF hospitalization is associated with effective, sustainable decongestion and better outcomes. bit.ly/4bIRYU1

#JACC #STRONGHF <a href="/ppponikowski/">Piotr Ponikowski</a> <a href="/DaniTomasoni_/">Daniela Tomasoni</a>
Andrew P. Ambrosy, MD (@kpheartdoc) 's Twitter Profile Photo

Form smart scales to digital biomarkers to improve remote patient monitoring in between discrete clinical encounters (link.springer.com/article/10.100…). Out now in #HREV by Marat Fudim, MD MHS and colleagues. Great overview of emerging tech! Marat Fudim, MD MHS Tor Biering-Sørensen, MD, MSc, MPH, PhD Steve Greene Andrew J Sauer MD

BiykemBozkurt (@biykemb) 's Twitter Profile Photo

In #STRONGHF, did the safety and efficacy of GDMT titration differ according to the severity of HF risk profile? #JACCHF @jaccjournals jacc.org/doi/10.1016/j.… @adriaanvoors Jozine ter Maaten

In #STRONGHF, did the safety and efficacy of GDMT titration differ according to the severity of HF risk profile? #JACCHF @jaccjournals jacc.org/doi/10.1016/j.…  @adriaanvoors <a href="/jozinetm/">Jozine ter Maaten</a>
Andrew P. Ambrosy, MD (@kpheartdoc) 's Twitter Profile Photo

HCM is the most common genetic heart disease, with non-obstructive HCM lacking evidence-based treatments. IMPROVE-HCM study assesses the safety and efficacy of ninerafaxstat, a novel cardiac mitotrope. Read more! (link.springer.com/article/10.100…) Daniela Tomasoni #HREV

HFAPresident (@hfa_president) 's Twitter Profile Photo

Applications are open to become *Fellow of the HFA (FHFA)* 🏅 Get the recognition you deserve for your professional achievements. ➡️ open to HFA Gold members ➡️ deadline 31 October ➡️ candidates must demonstrate high-level contributions in at least one of the following

Applications are open to become *Fellow of the HFA (FHFA)* 🏅

Get the recognition you deserve for your professional achievements.

➡️ open to HFA Gold members 
➡️ deadline 31 October
➡️ candidates must demonstrate high-level contributions in at least one of the following
Cornelia Margineanu (@corneliacrm) 's Twitter Profile Photo

We are back with the next HFA Journal Club—where cutting-edge research meets real talk. 📷📷 FREE for HFA members This Wednesday 23/10 | 📷 18:00 (CEST) Jozine ter Maaten Henrike Arfsten Sotiria Liori Antonio Cannata' Novi Yanti Sari European Society of Cardiology HFAPresident #HFAYoung esc365.escardio.org/event/1731